Your Power Isn't Just Declining With Age. Your Genes Set the Speed of That Decline.

Testosterone does not build or maintain muscle on its own. It has to dock onto the androgen receptor, the protein encoded by AR, to deliver its signal. The strength of that signal depends partly on a stretch of repeating CAG units inside the gene. Think of it as the volume knob that decides how loudly your muscle hears the same amount of testosterone.

The length of that CAG repeat varies considerably from person to person. **Shorter CAG repeats make the receptor more sensitive to testosterone, while longer repeats blunt the response so the same hormone level produces a weaker muscle-building signal.** If you carry a longer-repeat version of AR, your muscle is essentially listening to your testosterone at a lower volume than someone with a shorter repeat.

Day to day, this is why your bloodwork can show normal testosterone while your strength still erodes. The hormone is present, but your muscle is responding to it less efficiently, so the natural age-related dip in testosterone hits your power harder than it would hit a more sensitive athlete.

IGF1 codes for insulin-like growth factor 1, one of the main drivers of muscle protein synthesis and tissue repair. Every time you train, IGF1 signaling helps turn that stimulus into new contractile tissue and rebuilt fibers. It is a central part of how your body translates a hard session into actual strength.

A CA-repeat region and the rs35767 variant in IGF1 influence how much of this growth factor you produce and how strongly your muscle responds to it. **Certain IGF1 variants are linked to a weaker hypertrophy response and a faster age-related decline in muscle and strength.** These variants are common across the general population, which makes them a frequent hidden reason that two people on the same program get very different results.

Day to day, this can look like working just as hard as everyone else but seeing your muscle and power return diminish each year. Your body is building back less from the same stimulus, so the gains that used to come easily now require far more work to hold onto.

MSTN produces myostatin, the body’s built-in brake on muscle growth. Its job is to stop muscle from expanding without limit, keeping your tissue within a genetically set ceiling. Less myostatin signaling means a higher ceiling for muscle mass and explosive power.

The K153R variant (rs1805086) changes myostatin activity, and the R allele that raises the muscle ceiling is rare in the general population. **Most people carry the common version, which keeps myostatin’s brake firmly applied and sets a more modest limit on how much muscle and power they can build.** Knowing where you sit tells you how much of your power potential is structural versus trainable.

In practice, if you carry the common high-myostatin pattern, you may find your strength gains plateau sooner than you expect, which makes preserving the explosive muscle you already have a higher priority than chasing endless new growth.

ACTN3 builds alpha-actinin-3, a structural protein found almost exclusively in fast-twitch muscle fibers, the fibers responsible for explosive, powerful movement. It reinforces these fibers so they can produce force quickly, which is exactly what jumping, sprinting, and heavy power lifts demand.

The R577X variant (rs1815739) can knock out functional ACTN3 entirely. **Roughly 18% of people of European ancestry carry the X/X null genotype and produce no functional alpha-actinin-3, which reduces explosive power while often favoring an endurance profile.** Your fast-twitch fibers still work, but they lose a structural reinforcement built for raw power output.

If you are an X/X carrier, you may notice that your strength endurance holds up well while your truly explosive efforts, the one-rep maxes and the standing jumps, fade faster with age. That is the power-specific cost of missing this fast-twitch protein showing up exactly where you feel it most.

VDR is the vitamin D receptor, the protein that lets vitamin D do its work inside muscle. Vitamin D is required for muscle protein synthesis and the calcium signaling that powers contraction and repair. Without a well-functioning receptor, even good vitamin D levels cannot fully reach the muscle machinery.

The BsmI and FokI variants in VDR change how effectively this receptor operates. **Roughly 30 to 50% of people carry variants that impair recovery and training adaptation, even when their blood vitamin D looks adequate.** The hormone is in the tank, but the receptor is not passing the full signal to your muscle.

This is why some athletes recover slowly and adapt poorly to training despite normal vitamin D bloodwork. If your VDR is less efficient, every hard power session leaves you under-recovered, and over time that recovery debt shows up as stalled or declining power.

SOD2 produces the mitochondrial antioxidant enzyme that clears the oxidative stress your muscles generate during hard training. Powerful efforts flood your cells with free radicals, and SOD2 is the frontline cleanup crew that neutralizes them so your muscle can recover and rebuild.

The Val16Ala variant (rs4880) changes how efficiently this enzyme reaches the mitochondria where the damage happens. **Roughly 40% of people are homozygous for the variant that impairs oxidative stress clearance, leaving them with higher muscle damage, slower recovery, and greater susceptibility to delayed onset muscle soreness.** The harder you train for power, the more this bottleneck costs you.

If you carry this pattern, you probably feel it as soreness that lingers longer than it should and sessions that leave you flattened for days. As you age and your antioxidant capacity naturally declines, this slower clearance compounds, eating into the recovery you need to maintain explosive power.